Authors: Newbold, P Jackson, DM Young, A Dougall, IG Ince, F Rocchiccioli, KMS Holt, PR

Citation: P. Newbold et al., Dual D-2 dopamine receptor and beta(2)-adrenoceptor agonists for the modulation of sensory nerves in COPD, PROG R RES, 31, 2001, pp. 68-71

Authors: Dougall, IG

Citation: Ig. Dougall, Functional methods for quantifying agonists and antagonists (Reprinted from Receptor-Based Drug Design, vol 89, pg 25-48, 1998), J RECEPT SI, 21(2-3), 2001, pp. 117-137

Authors: Fagura, MS Jarvis, GE Dougall, IG Leff, P

Citation: Ms. Fagura et al., Adventures in the pharmacological analysis of P2 receptors, J AUTON NER, 81(1-3), 2000, pp. 178-186

Authors: Marriott, DP Dougall, IG Meghani, P Liu, YJ Flower, DR

Citation: Dp. Marriott et al., Lead generation using pharmacophore mapping and three-dimensional databasesearching: Application to muscarinic M-3 receptor antagonists, J MED CHEM, 42(17), 1999, pp. 3210-3216

Authors: Bonnert, RV Brown, RC Chapman, D Cheshire, DR Dixon, J Ince, F Kinchin, EC Lyons, AJ Davis, AM Hallam, C Harper, ST Unitt, JF Dougall, IG Jackson, DM McKechnie, K Young, A Simpson, WT

Citation: Rv. Bonnert et al., Dual D-2-receptor and beta(2)-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues, J MED CHEM, 41(25), 1998, pp. 4915-4917